The percentage of patients with a new diagnosis of hypertension (diagnosed on or after 1 April 2014) which has been confirmed by ambulatory blood...
The percentage of patients registered at the practice aged 65 years and over who have been diagnosed with one or more of the following conditions:...
The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma
1 How do I control my blood pressure? Lifestyle options and choice of medicines Patient decision aid c NICE 2019. All rights reserved. Subject to...
Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
We work with an independent Indicator Advisory Committee (IAC) to develop indicators suitable for potential inclusion in the Quality and Outcomes...
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.
Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for type 1 diabetes not controlled by insulin therapy alone in adults with a BMI of at
This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
Evidence-based recommendations on olaparib (Lynparza) for treating BRCA mutation-positive, advanced ovarian, fallopian tube or primary peritoneal cancer
Methodology day presentations - 13 June 2019 Principles underlying the development of NICE guidance - Steven Barnes. An introduction to how health
Everything NICE has said on managing hypertension in adults in an interactive flowchart
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
Everything NICE has said on how community pharmacies can promote health and wellbeing in an interactive flowchart
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
NICE apps for android and apple devices. Includes BNF, BNFC and NICE guidance.
NICE has today (23 August 2019) announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating 2 types of severe treatment-resistant epilepsy.
Outside interests of the NICE senior management team
Workshops to help voluntary and community sector organisations learn more about NICE's activities
NICE research projects and partners.
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
Please complete all the required fields before submitting the form.RWE Navigator feedback form 1. Please tell us about yourself. Which
Chief executive has been at the helm of the institute since it was founded in April 1999
Everything NICE has said on changing people's health-related behaviours, including interventions aimed at over 16s, in an interactive flowchart
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. Who we are
Our express service is designed for companies who need to receive scientific advice within more challenging timeframes. Within 12 weeks, you'll...
Scientific advice medtech advice
Book one of our scientific advice team to speak at your event
Find out more about why engaging with us early is important. We will: introduce NICE present NICE Scientific Advice explain how to complete the
Training seminars and workshops for those in the pharmaceutical, medical technology or cell and gene therapy sectors
Advice on improving the quality of economic models
Scientific advice for developers of pharmaceuticals
Promoting independence through intermediate care - a quick guide for staff delivering intermediate care services.
Designed for developers of medicinal products and other similarly regulated technologies. Receive advice from NICE, the European Medicines Agency...
Advice from NICE to help you generate evidence to inform future NICE evaluations and to enable market access
Designed for those seeking advice in either pharmaceutical or medical technologies. Provides the highest level of detail of all our advice processes.
Designed for developers of medicinal products and other similarly regulated technologies. Allows you to seek joint regulatory advice from the...
Feedback from the GP reference panel survey
NICE Evidence Services issues View the latest issues affecting NICE Evidence Services (Healthcare Databases Advanced Search(HDAS), Evidence Search
Evidence-based recommendations on risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults
Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...
Everything NICE has said on psoriasis in an interactive flowchart
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart
Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart
This quality standard covers the assessment, management and care provided for people aged 14 and over who have coexisting severe mental illness and substance misuse. It describes high-quality care in priority areas for improvement.
Everything NICE has said about assessing and managing coexisting severe mental illness and substance misuse in healthcare settings in an interactive flowchart